Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.
about
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial.Regression of cardiac amyloidosis following stem cell transplantation: a comparison between echocardiography and cardiac magnetic resonance imaging in long-term survivors.An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.Recent improvements in survival in primary systemic amyloidosis and the importance of an early mortality risk score.Induction therapy with bortezomib and dexamethasone followed by autologous stem cell transplantation versus autologous stem cell transplantation alone in the treatment of renal AL amyloidosis: a randomized controlled trialAutologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.Amyloidosis: 2008 BMT Tandem Meetings (February 13-17, San Diego).Current status of hematopoietic cell transplantation in the treatment of systemic amyloid light-chain amyloidosis.Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant.Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006.Clinical implications of gastrointestinal symptoms in systemic amyloidosis.Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.AbstractsAutologous Stem Cell and Kidney Transplantation for Primary Amyloidosis Associated with ESRD: Which Should Come First?Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effectsResults of autologous stem cell transplantation for AL amyloidosis in one Czech center
P2860
Q31032765-FE5BE8C8-161B-415A-99B3-62CC6DA59BFCQ33753528-BBBF5710-4242-4C9F-895A-D73878A60F9AQ34435465-9D51A3DF-EF10-4748-B6FB-BEA2CA15D57BQ34450910-52D8AA65-4494-4833-BB51-24B77FB7D458Q35081363-65AA442E-7D9B-474D-A363-1B86B350AD0DQ36215543-631F9AD2-3C9E-43F1-B676-532A42FAA1DBQ37045900-D13F4EDA-79FC-49B6-A648-D7A931A2B6DDQ37904673-1A8A1222-B552-45DA-B97F-2D1F52B8E286Q40516456-28E100CF-0A89-49EC-824B-A5B75FBCE0D7Q42879120-686B3408-6E90-4AA7-BB63-653B9F207404Q44468671-89363C9C-CBAA-4005-9468-BC482B9A49C8Q48198950-4202EF39-4E32-4EA4-A185-79A228CD9F46Q48313100-5311F2B3-E2C2-42B1-A59D-FAE50677E5DAQ52957346-D41EC3BA-A63D-4C4D-B514-ECE58C264FD1Q53067739-618A6476-5CA4-40A7-9DFE-37DAC22B0474Q57259399-2A3D4ABE-E88F-478F-8587-79D4D830EFC8Q57702876-07612CAA-0B91-4A0A-8623-13C0059B44C2Q58030146-6475829B-C6E3-49CC-9A29-4C7FB15D156EQ58125071-9189696E-5718-4248-9C01-2BED50578B91
P2860
Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@ast
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@en
type
label
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@ast
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@en
prefLabel
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@ast
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@en
P2093
P2860
P356
P1476
Myeloablative chemotherapy wit ...... amyloidosis: a status report.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1702178
P407
P577
2000-03-01T00:00:00Z
P5875
P6179
1042270755